Irene García
Hospital La Paz · Hospital Universitario La Paz
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Irene García as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:54 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06366932 · Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive ModelsInstituto de Investigación Hospital Universitario La Paz · unknown · Atopic Dermatitis · principal investigator
- Ph2/Ph3NCT04353128 · Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.Instituto de Investigación Hospital Universitario La Paz · completed · Covid19, SARS-CoV 2, Coronavirus Infection · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:54 UTC. The ranking covers the 200 most relevant of 64 PubMed records, and a shared surname and initials can bring in a namesake. All 64 on PubMed
- Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.NIPH Ann · 1991355 citationsRCR 10.5
- Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients.Ann Surg · 2002350 citationsRCR 10.0
- Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.Blood · 2001179 citationsRCR 4.3
- Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease.J Natl Cancer Inst · 1988113 citationsRCR 4.3
- Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up.Obes Surg · 2011109 citationsRCR 3.8
- Tear proteome and protein network analyses reveal a novel pentamarker panel for tear film characterization in dry eye and meibomian gland dysfunction.J Proteomics · 201393 citationsRCR 4.1
- 86 citationsRCR 3.5
- Diagnostic evaluation of patients with nonimmediate cutaneous hypersensitivity reactions to iodinated contrast media.Allergy · 201282 citationsRCR 3.7
- Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study.J Acquir Immune Defic Syndr · 200971 citationsRCR 2.0
- Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188 Re in adult recurrent high-grade glioma.Cancer Biol Ther · 200862 citationsRCR 1.5